GlassScriptPhysician profile
Stephen K Otey
NPI 1104977560
$1,710.99
in general payments reported to CMS, 2019-2025
14 companies · $72.84 in 2025
The $72.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $117 · 2021: $111 · 2022: $96.34 · 2023: $43.68 · 2024: $120 · 2025: $72.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,015.83 | 2019 | |
| Daiichi Sankyo INC. | $175.77 | 2020-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $143.54 | 2019-2024 | |
| Abbvie INC. | $77.53 | 2019-2021 | |
| Astellas Pharma US INC | $56.65 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $50.72 | 2019-2022 | |
| Amgen INC. | $40.56 | 2019-2025 | Evenity |
| Mayne Pharma Commercial LLC | $34.01 | 2025 | |
| Hologic Sales and Service, LLC | $28.28 | 2019-2023 | Acessa Provu System |
| Ethicon US, LLC | $27.35 | 2019 | |
| Becton, Dickinson and Company | $17.83 | 2023 | Bd Affirm Vpiii Microbial Identification Test |
| Xeris Pharmaceuticals, INC. | $16.07 | 2021 | |
| Merck Sharp & Dohme LLC | $13.75 | 2019 | |
| Exeltis, USA INC. | $13.10 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Otey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.